Chelsea Counsel CO Bristol Myers Squibb CO Transaction History

Chelsea Counsel CO

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 23, 2023	BUY	$68.48 - $81.09 $2,396 - $2,838	35 New	35 $2,000
Q4 2020 Mar 08, 2022	SELL	$57.74 - $65.43 $20,324 - $23,031	-352 Reduced 7.97%	4,063 $252,000
Q3 2020 May 06, 2022	BUY	$57.43 - $63.64 $8,097 - $8,973	141 Added 3.3%	4,415 $266,000
Q2 2020 May 06, 2022	BUY	$54.82 - $64.09 $234,300 - $273,920	4,274 New	4,274 $251,000
Q3 2019 Mar 23, 2020	SELL	$42.77 - $50.71 $193,234 - $229,107	-4,518 Closed	0 $0
Q1 2019 Dec 09, 2019	BUY	$45.12 - $53.8 $203,852 - $243,068	4,518 New	4,518 $216,000
Q4 2017 Jan 12, 2018	SELL	$59.94 - $65.35 $201,578 - $219,772	-3,363 Closed	0 $0
Q3 2017 Jan 12, 2018	BUY	$55.23 - $63.74 $185,738 - $214,357	3,363	3,363 $214,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Chelsea Counsel CO, based on Form 13F filings with the SEC.

Stay updated on Chelsea Counsel CO with notifications on news.